Previous 10 | Next 10 |
DUBLIN, Ireland, March 31, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company with expertise in protein misfolding, today announced that baseline data from the Phase 2 PASADENA study of prasinezumab in patients with early Parkinson’s d...
The following slide deck was published by Prothena Corporation plc in conjunction with their 2019 Q4 earnings Read more ...
Image source: The Motley Fool. Prothena (NASDAQ: PRTA) Q4 2019 Earnings Call Feb 12, 2020 , 4:30 p.m. ET Operator Continue reading
Prothena Corporation (PRTA) Q4 2019 Earnings Conference Call February 12, 2020, 16:30 ET Company Participants Randy Fawcett - SVP, Finance and Operations Gene Kinney - President, CEO & Director Tran Nguyen - CFO & COO Conference Call Participants Christopher Marai ...
Prothena (NASDAQ: PRTA ): Q4 GAAP EPS of -$0.54 beats by $0.06 . More news on: Prothena Corporation plc, Earnings news and commentary, Healthcare stocks news, Read more ...
Net cash used in operating and investing activities was $14.6 million in the fourth quarter and $53.5 million for the full year 2019; quarter-end cash and restricted cash position of $378.4 million provides funding to advance a broad pipeline Reported interim data from Phase 1 stud...
DUBLIN, Ireland, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company with expertise in protein misfolding, announced today that it will report its fourth quarter and full year 2019 financial results on Wednesday, February 12, 2020 aft...
Gainers: CLPS (NASDAQ: CLPS ) +68% . More news on: CLPS Incorporation, Microbot Medical Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...
Gainers: Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on multiple discriminant analysis ((MDA)) breakout selections over more than five years. This subset of the different portfolios I regularly analyze has now reached 135 weeks of public selections as part of t...
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
Prothena Corporation plc Website:
2024-07-03 23:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-02 10:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will initiate a Phase 1 clinical trial for PRX019 in 2024 Prothena Corporation plc (NASDAQ:PRTA),...